Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-046732

Chief Executive Officer sold 15,416 shares at an average $2.57 ($39,664)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Brainard Diana · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-08-17 Sale : show line 1 in the form 10b5-1 −11,361 $2.50 $28,351 895,938 D
2023-08-18 Sale : show line 2 in the form 10b5-1 −4,055 $2.79 $11,313 891,883 D
Open-market sales · 15,416 sh · avg $2.57 · $39,664
Loading xslF345X05/doc4.xml…